Total Payments
$53,032
2024 Payments
$1,355
Companies
60
Transactions
785
Medicare Patients
5,570
Medicare Billing
$800,009
Payment Breakdown by Category
Consulting$16,850 (31.8%)
Food & Beverage$16,107 (30.4%)
Travel$11,408 (21.5%)
Other$8,500 (16.0%)
Education$167.51 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $16,850 | 7 | 31.8% |
| Food and Beverage | $16,107 | 732 | 30.4% |
| Travel and Lodging | $11,408 | 36 | 21.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,500 | 6 | 16.0% |
| Education | $167.51 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ARALEZ PHARMACEUTICALS US INC. | $19,761 | 39 | $0 (2018) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $10,353 | 72 | $0 (2024) |
| Abbott Laboratories | $5,788 | 56 | $0 (2024) |
| Penumbra, Inc. | $3,667 | 15 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $2,119 | 190 | $0 (2024) |
| Boston Scientific Corporation | $1,592 | 13 | $0 (2024) |
| Inari Medical, Inc. | $1,574 | 5 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $679.81 | 49 | $0 (2024) |
| Amgen Inc. | $612.15 | 33 | $0 (2024) |
| Philips Electronics North America Corporation | $529.29 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,355 | 62 | Abbott Laboratories ($304.62) |
| 2023 | $3,291 | 99 | Inari Medical, Inc. ($1,574) |
| 2022 | $6,524 | 105 | Penumbra, Inc. ($2,359) |
| 2021 | $1,911 | 112 | Novartis Pharmaceuticals Corporation ($553.50) |
| 2020 | $1,451 | 68 | Abbott Laboratories ($505.32) |
| 2019 | $5,184 | 82 | Abbott Laboratories ($2,560) |
| 2018 | $6,796 | 111 | ARALEZ PHARMACEUTICALS US INC. ($4,417) |
| 2017 | $26,521 | 146 | Aralez Pharmaceuticals US Inc. ($15,344) |
All Payment Transactions
785 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/13/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $31.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.53 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Cardiology | ||||||
| 12/09/2024 | Abbott Laboratories | AMPLATZER TALISMAN (Device) | Food and Beverage | In-kind items and services | $2.68 | General |
| Category: Structural Heart | ||||||
| 12/05/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.35 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/18/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $2.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $1.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Not Applicable | ||||||
| 10/04/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Structural Heart | ||||||
| 09/26/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $4.85 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/23/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Not Applicable | ||||||
| 07/23/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Structural Heart | ||||||
| 07/18/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/28/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/26/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/21/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Structural Heart | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,383 | 3,287 | $863,953 | $188,120 |
| 2022 | 32 | 1,364 | 2,302 | $717,270 | $178,370 |
| 2021 | 29 | 1,293 | 2,443 | $777,988 | $202,127 |
| 2020 | 33 | 1,530 | 2,732 | $1.0M | $231,391 |
Total Patients
5,570
Total Services
10,764
Medicare Billing
$800,009
Procedure Codes
126
All Medicare Procedures & Services
126 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 174 | 328 | $127,582 | $40,924 | 32.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 81 | 471 | $85,193 | $16,278 | 19.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 81 | 415 | $74,285 | $14,958 | 20.1% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 48 | 283 | $70,750 | $14,925 | 21.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 105 | 108 | $124,400 | $14,630 | 11.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 44 | 44 | $91,275 | $14,303 | 15.7% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 44 | 90 | $68,000 | $9,343 | 13.7% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 13 | 13 | $15,200 | $8,292 | 54.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 60 | 74 | $17,094 | $6,823 | 39.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 33 | 33 | $9,180 | $5,265 | 57.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 29 | 120 | $15,000 | $5,222 | 34.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 56 | 84 | $18,648 | $5,217 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 44 | 54 | $14,839 | $4,913 | 33.1% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 42 | 253 | $16,445 | $4,822 | 29.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 195 | 394 | $29,422 | $4,150 | 14.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 25 | 27 | $12,150 | $3,573 | 29.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 23 | $9,683 | $3,075 | 31.8% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 25 | 77 | $6,930 | $1,628 | 23.5% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 34 | 104 | $11,940 | $1,577 | 13.2% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 28 | 47 | $6,674 | $1,420 | 21.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 26 | 26 | $10,740 | $1,414 | 13.2% |
| G0400 | Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels | Office | 2023 | 11 | 22 | $3,795 | $1,333 | 35.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 18 | 18 | $5,308 | $888.92 | 16.7% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 16 | 18 | $2,380 | $746.25 | 31.4% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 14 | 14 | $8,339 | $684.22 | 8.2% |
About Dr. Sanjaya Saheta, MD
Dr. Sanjaya Saheta, MD is a Cardiovascular Disease healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1891779062.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sanjaya Saheta, MD has received a total of $53,032 in payments from pharmaceutical and medical device companies, with $1,355 received in 2024. These payments were reported across 785 transactions from 60 companies. The most common payment nature is "Consulting Fee" ($16,850).
As a Medicare-enrolled provider, Saheta has provided services to 5,570 Medicare beneficiaries, totaling 10,764 services with total Medicare billing of $800,009. Data is available for 4 years (2020–2023), covering 126 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease, Interventional Cardiology
- Location Saint Louis, MO
- Active Since 12/01/2005
- Last Updated 08/21/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1891779062
Products in Payments
- LifeVest (Device) $10,353
- ZONTIVITY (Drug) $10,246
- YOSPRALA (Drug) $9,515
- Indigo System (Device) $2,359
- Xience V coronary stent system (Device) $2,188
- ENTRESTO (Drug) $1,897
- AMPLATZER AMULET (Device) $1,714
- FLOWTRIEVER CATHETER, S (Device) $1,394
- VersaCross Access Solution (Device) $1,322
- Indigo (Device) $1,309
- XARELTO (Drug) $679.81
- Omnilink Elite vascular stent system (Device) $469.19
- Arcalyst (Drug) $402.78
- ELIQUIS (Drug) $394.24
- Supera peripheral stent system (Device) $388.28
- Fox Sv PTA catheter and Armada 14 percutaneous catheter and Viatrac 14 Plus peripheral catheter (Device) $377.10
- BRILINTA (Drug) $335.14
- Corlanor (Drug) $327.59
- NEXLETOL (Drug) $296.91
- JARDIANCE (Drug) $261.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Saint Louis
Dr. Jasvindar Singh, Md, MD
Cardiovascular Disease — Payments: $883,337
Cardiovascular Disease $883,337
Dr. Harvey Serota, M.d, M.D
Cardiovascular Disease — Payments: $730,638
Cardiovascular Disease $730,638
Dr. Daniel Kelly, Md, MD
Cardiovascular Disease — Payments: $538,763
Cardiovascular Disease $538,763
Dr. Alan Zajarias, Md, MD
Cardiovascular Disease — Payments: $195,866
Cardiovascular Disease $195,866
Dr. George Kichura, M.d, M.D
Cardiovascular Disease — Payments: $194,189
Cardiovascular Disease $194,189
Dr. Anish Thomas, M.d, M.D
Cardiovascular Disease — Payments: $189,906
Cardiovascular Disease $189,906